SCHEMBL1230982

SCHEMBL1230982

FC(F)(F)c1ccn(-c2[c]nc3ccccc3c2)n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.40
MAPT P10636 4/20 0.40
RAB9A P51151 4/20 0.40
PDE10A Q9Y233 1/20 0.38
PRMT6 Q96LA8 1/20 0.37
NPSR1 Q6W5P4 3/20 0.36
IDH1 O75874 6/20 0.34
IDH2 P48735 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.33
MGLL Q99685 1/20 0.33
POLB P06746 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTT P42858 1/20 0.32
PAX8 Q06710 1/20 0.32
ADRB2 P07550 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4061700 0.70 NPC1 (0.43) NPC1MAPTRAB9APDE10APRMT6
SCHEMBL5250342 0.69 MAPT (0.41) NPC1MAPTRAB9ANPSR1KDM4E
SCHEMBL1094013 0.67 NPC1 (0.63) NPC1MAPTRAB9APRMT6NPSR1
SCHEMBL5802745 0.66 ADRB2 (0.43) NPC1MAPTRAB9APDE10APRMT6
SCHEMBL30552781 0.66 PRMT6 (0.45) NPC1MAPTRAB9APDE10APRMT6
SCHEMBL5545937 0.64 PRMT6 (0.42) NPC1MAPTRAB9APRMT6NPSR1
SCHEMBL1230980 0.64 ALDH1A1 (0.31) MAPTALDH1A1
SCHEMBL3724060 0.64 IDH1 (0.31) MAPTIDH1ALDH1A1
SCHEMBL4434312 0.64 MAPT (0.43) NPC1MAPTRAB9APRMT6NPSR1
SCHEMBL4429679 0.64 PRMT6 (0.43) NPC1MAPTRAB9APDE10APRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP disclosed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO disclosed